Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14 | WHO Drug Information | journal | 0.102 Q4 | 11 | 5 | 26 | 15 | 1 | 20 | 0.06 | 3.00 | 33.33 | |
13 | Medical Cannabis and Cannabinoids | journal | 0.731 Q2 | 13 | 19 | 41 | 621 | 168 | 34 | 3.65 | 32.68 | 39.53 | |
12 | Chemotherapy | journal | 0.663 Q2 | 61 | 30 | 97 | 866 | 219 | 92 | 1.84 | 28.87 | 35.75 | |
11 | EJNMMI Radiopharmacy and Chemistry | journal | 0.869 Q2 | 28 | 42 | 99 | 1553 | 398 | 95 | 3.59 | 36.98 | 37.30 | |
10 | Drugs - Real World Outcomes | journal | 0.564 Q2 | 21 | 63 | 152 | 2205 | 336 | 150 | 2.16 | 35.00 | 46.28 | |
9 | Frontiers in Medical Technology | journal | 0.602 Q2 | 15 | 67 | 210 | 2797 | 661 | 193 | 2.60 | 41.75 | 34.72 | |
8 | PharmacoEconomics - Open | journal | 0.658 Q2 | 20 | 74 | 207 | 3193 | 381 | 197 | 1.94 | 43.15 | 43.63 | |
7 | Cardiology | journal | 0.547 Q2 | 72 | 84 | 294 | 2355 | 471 | 256 | 1.68 | 28.04 | 30.35 | |
6 | Inflammopharmacology | journal | 0.952 Q1 | 68 | 247 | 448 | 18084 | 2226 | 432 | 4.65 | 73.21 | 46.20 | |
5 | Advances in Therapy | journal | 1.089 Q1 | 83 | 347 | 1113 | 13832 | 4296 | 1039 | 3.40 | 39.86 | 43.35 | |
4 | Journal of Cardiovascular Development and Disease | journal | 0.621 Q2 | 32 | 497 | 709 | 27150 | 1727 | 700 | 2.40 | 54.63 | 33.67 | |
3 | Antibiotics | journal | 0.920 Q1 | 77 | 1729 | 4319 | 112476 | 20751 | 4258 | 4.45 | 65.05 | 49.00 | |
2 | Vaccines | journal | 1.201 Q1 | 85 | 1854 | 4462 | 105389 | 22996 | 4375 | 5.37 | 56.84 | 46.93 | |
1 | Frontiers in Pharmacology | journal | 1.066 Q1 | 154 | 3463 | 11918 | 215854 | 56071 | 11495 | 4.32 | 62.33 | 45.82 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®